395 related articles for article (PubMed ID: 32286604)
21. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
[TBL] [Abstract][Full Text] [Related]
22. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
Tian W; Wang D; Wang Z; Jiang K; Li Z; Tian Y; Kang X; Liu X; Li H
Gene; 2021 Jan; 764():145094. PubMed ID: 32860898
[TBL] [Abstract][Full Text] [Related]
23. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
[TBL] [Abstract][Full Text] [Related]
24. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
25. Long-chain acyl-CoA synthetase-4 regulates endometrial decidualization through a fatty acid β-oxidation pathway rather than lipid droplet accumulation.
Zhang H; Sun Q; Dong H; Jin Z; Li M; Jin S; Zeng X; Fan J; Kong Y
Mol Metab; 2024 Jun; 84():101953. PubMed ID: 38710444
[TBL] [Abstract][Full Text] [Related]
26. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
27. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
Wu M; Liu H; Chen W; Fujimoto Y; Liu J
Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
[TBL] [Abstract][Full Text] [Related]
28. ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription.
Wu D; Zuo Z; Sun X; Li X; Yin F; Yin W
Biochem Pharmacol; 2024 Jun; 224():116206. PubMed ID: 38615921
[TBL] [Abstract][Full Text] [Related]
29. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
Kuwata H; Hara S
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
[TBL] [Abstract][Full Text] [Related]
30. Acsl, the Drosophila ortholog of intellectual-disability-related ACSL4, inhibits synaptic growth by altered lipids.
Huang Y; Huang S; Lam SM; Liu Z; Shui G; Zhang YQ
J Cell Sci; 2016 Nov; 129(21):4034-4045. PubMed ID: 27656110
[TBL] [Abstract][Full Text] [Related]
31. ACSL3 and GSK-3β are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells.
Chang YS; Tsai CT; Huangfu CA; Huang WY; Lei HY; Lin CF; Su IJ; Chang WT; Wu PH; Chen YT; Hung JH; Young KC; Lai MD
J Cell Biochem; 2011 Mar; 112(3):881-93. PubMed ID: 21328461
[TBL] [Abstract][Full Text] [Related]
32. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.
Yan S; Yang XF; Liu HL; Fu N; Ouyang Y; Qing K
World J Gastroenterol; 2015 Mar; 21(12):3492-8. PubMed ID: 25834313
[TBL] [Abstract][Full Text] [Related]
33. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.
Dong B; Kan CF; Singh AB; Liu J
J Lipid Res; 2013 May; 54(5):1241-54. PubMed ID: 23427282
[TBL] [Abstract][Full Text] [Related]
34. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
35. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
[TBL] [Abstract][Full Text] [Related]
36. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet.
Mashek DG; Li LO; Coleman RA
J Lipid Res; 2006 Sep; 47(9):2004-10. PubMed ID: 16772660
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
38. Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.
Shimbara-Matsubayashi S; Kuwata H; Tanaka N; Kato M; Hara S
Biol Pharm Bull; 2019; 42(5):850-855. PubMed ID: 31061331
[TBL] [Abstract][Full Text] [Related]
39. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
40. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
